ReviewFrontiers in cell and developmental biology2022
Synovial sarcoma of the head and neck: A review of reported cases on the clinical characteristics and treatment methods.
Review in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 22 citations in OpenAlex.
- Article
- [Synovial sarcoma of the parotid gland: a case report].The Pan African medical journal · 2026Article
- Biphasic Synovial Sarcoma of the Palatine Tonsil: A Case Report and Literature Review.Clinical case reports · 2025Article
- Decisive role of surgery on improving overall survival outcomes of primary thyroid sarcoma: the first long-term cohort study.Endocrine · 2025Article
- Pediatic intracranial synovial sarcoma: a case report.Discover oncology · 2025Article
- Pharmacologic degradation of WDR5 suppresses oncogenic activities of SS18::SSX and provides a therapeutic of synovial sarcoma.Science advances · 2025Article
- Head and neck synovial sarcoma in a woman with previous lymphoma and papillary thyroid carcinoma.Pathologica · 2025Article
- Pediatric tonsillar synovial sarcoma: extremely rare case report.Frontiers in pediatrics · 2025Article
- An unusual presentation of primary synovial sarcoma of the ethmoid sinus in a 54-year-old woman: A case report and literature review.International journal of surgery case reports · 2025Article
- A Rare Case of Primary Laryngeal Synovial Sarcoma, Challenges in Diagnosis and Management in a Resource-Limited Setup: A Case Report.Case reports in otolaryngology · 2025Article
- Oncologic Outcomes in Patients with Localized, Primary Head and Neck Synovial Sarcoma.Cancers · 2024Article
- Fungating synovial sarcoma at the posterior aspect of neck: a case report.Journal of medical case reports · 2024Article
- Tonsillar synovial sarcoma, unusual anatomical location: case report and literature review.Diagnostic pathology · 2024Review
- Extraskeletal myxoid chondrosarcoma of the gingival: a rare case report and review of the literature.Diagnostic pathology · 2023Review
- General Commentary: Synovial sarcoma of the head and neck: A review of reported cases on the clinical characteristics and treatment methods.Frontiers in cell and developmental biology · 2023Article
Corrections and comments
- Commented on by
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synovial sarcoma (SS) is a high-grade soft-tissue sarcoma that occurs predominantly in older children and young adults in their thirties. It is usually very challenging to diagnose and treat synovial sarcoma in the head and neck region. The purpose of this review is to investigate the clinical manifestations and different treatment methods in the management of primary synovial sarcoma of the head and neck. HNSS has an aggressive nature and poor prognosis. Surgical resection, radiotherapy, and chemotherapy are the primary treatment methods. Typically, surgical resection with negative margins remains the foundation of therapy, which is not very easily achieved in the head and neck due to its complex anatomical structure and the presence of many blood vessels and nerves. However, synovial sarcoma has a high recurrence rate, so aggressive management and close follow-up are warranted for the optimal outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.